Health technology assessment of fixed-dose combination regimen in treatment of newly diagnosed smear-positive pulmonary tuberculosis: A meta-analysis
Open Access
- 1 April 2020
- journal article
- review article
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 76 (2) , 192-200
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysisBrazilian Journal of Microbiology, 2017
- Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatmentClinics, 2015
- Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysisEuropean Respiratory Journal, 2013
- Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary TuberculosisJAMA, 2011
- Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.2009
- Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients.2008
- Fixed-Dose Combinations Improve Medication Compliance: A Meta-AnalysisThe American Journal of Medicine, 2007
- How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.1998
- The use of essential drugs. Eighth report of the WHO Expert Committee (including the revised Model List of Essential Drugs).1998
- The promise and reality of fixed-dose combinations with rifampicinTubercle and Lung Disease, 1994